Cardiovascular Device Update articles from February 2007

Cardiovascular Device Update archives from February 2007

Multiple issues offering large openings for second-generation devices in this device/drug arena.
February 1, 2007... DES 2.0 -- and beyond Multiple issues offering large openings for second-generation devices in this device/drug arena By DON LONG CDU Executive Editor The news for drug-eluting stents (DES) in 2006 wasn't good. For this...

Variety of exhibits, presentations within tight surgical target.
February 1, 2007... Variety of exhibits, presentations within tight surgical target By AMANDA PEDERSEN, CDU staff writer And LARRY HAIMOVITCH, CDU contributing writer SAN DIEGO -- Health conferences usually come with a clear target focus -- that is,...

For the record: FDA on DES safety.
February 1, 2007... For the record: FDA on DES safety Following the Dec. 7-8 meeting of the Circulatory System Devices Advisory Panel to discuss the reports of safety issues related to drug-eluting stents, the FDA issued a statement as follow-up to that...

Volcano catheters offered for DES trials, evaluation.
February 1, 2007... Volcano catheters offered for DES trials, evaluation Volcano (Rancho Cordova, California), Stanford University (Palo Alto, California), Cardialysis (Rotterdam, the Netherlands) and the Cardiovascular Research Foundation (CRF; New York) have...

International Report.
February 1, 2007... International Report New heart muscle able to be made from embryonic stem cells Researchers at the Technion-Israel Institute of Technology (Haifa) recently reported creating new heart muscle with its own blood supply using human...

Acquisition.
February 1, 2007... Acquisition * AngioDynamics (Queensbury, New York) closed its $220 million acquisition of Rita Medical Systems (Fremont, California). Each share of Rita common stock was converted into the right to receive 0.1722 of a share of common stock...

Business Developments.(Company overview)
February 1, 2007... Business Developments CardioMEMS seeks $87M in first IPO in med-tech for '07 A company focused on heart monitoring had the honor of kicking off the initial public offering year in the med-tech space last month. CardioMEMS (Atlanta), a...

Agreements.
February 1, 2007... Agreements * CryoLife (Kennesaw, Georgia) has entered an agreement with the Cleveland Clinic (Cleveland, Ohio) to develop an allograft heart valve for patients suffering from heart infections. The organizations will develop a combination...

Market Updates.
February 1, 2007... Market Updates Study: Alzheimer's recast as primarily cardio disorder A paper in the Jan. 16 issue of the Proceedings of the National Academy of Sciences casts Alzheimer's disease (AD) against type: as a cardiovascular disorder at its...

Personnel File.
February 1, 2007... Personnel File * Kenneth Freeman has been named executive chairman of Accellent (Wilmington, Massachusetts). The appointment of Freeman, a member of Accellent's board, was made in connection with the departure of Ron Sparks, president/CEO,...

Product Pipeline.
February 1, 2007... Product Pipeline ProRhythm studying high intensity US for treatment of AF To treat atrial fibrillation (AF), the main therapy is often medication. However, in about 60% of patients with AF, medication does not stop the symptoms,...

At presstime: Study verifies QuickOpt approach.(Clinical report)
February 1, 2007... At presstime . . . Study verifies QuickOpt approach Clinical trial results showing the effectiveness of a new approach for optimizing cardiac devices will be published in this month's issue of the peer-reviewed Journal of...